DEF: CareCloud Annual Meeting Proxy Statement Highlights
Proxy Statement
CareCloud, Inc. has issued its proxy statement for the June 4, 2026 Annual Meeting, detailing proposals for director elections, executive compensation, equity incentive plan approval, and auditor appointment.
Summary
- CareCloud, Inc. is holding its Annual Meeting of Shareholders on June 4, 2026, at its principal executive offices in Somerset, NJ.
- Key proposals include the election of directors Mahmud Haq and Cameron Munter, an advisory vote on executive compensation, approval of the 2026 Equity Incentive Plan, and the appointment of Tanner LLP as the independent registered public accounting firm for the year ending December 31, 2026.
- Shareholders of record as of April 7, 2026, are entitled to vote.
- The company is providing proxy materials electronically via a Notice of Internet Availability, with options for shareholders to request paper or email copies.
- The Board of Directors recommends a vote FOR all proposed items.
- The quorum requirement for the meeting has been reduced to 33.4% of outstanding shares.
- The filing also details security ownership by directors and major shareholders, corporate governance practices, board committee responsibilities, director compensation, and executive compensation through the Pay Versus Performance table.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, primarily serving as a procedural notice for the annual shareholder meeting with standard proposals. While the equity plan is a positive forward-looking initiative, the extensive disclosure of related-party transactions introduces a note of caution.
Positives
- The company is seeking shareholder approval for a new 2026 Equity Incentive Plan designed to align employee and director interests with shareholders and attract/retain talent.
- The Board of Directors is nominated with individuals possessing significant experience, including Mahmud Haq (founder, Executive Chairman) and Cameron Munter (former Ambassador, Nominating and Governance Committee Chair).
- The company has a clear process for director nominations and considers diversity in its selection criteria.
- Independent directors form the entirety of the Audit, Compensation, and Nominating and Corporate Governance committees.
- The company has a Related Person Transaction Policy in place to manage potential conflicts of interest.
Negatives
- The company has several related-party transactions disclosed, including leases of corporate offices and facilities from the Executive Chairman, sales to the physician wife of the Executive Chairman, and consulting agreements with entities owned by the son of the Executive Chairman.
- The company leased facilities from the Executive Chairman, incurring approximately $285,000 in rent expense for 2025 and $281,000 for 2024, with additional upgrade costs of $1.6 million in 2025 and $979,000 in 2024.
- The company employed the son of the CEO and entered into a consulting agreement with an entity owned by the son of the Executive Chairman.
- The company has had multiple changes in its independent registered public accounting firm, with Rosenberg Rich Baker Berman, P.A. resigning on August 14, 2025, and Tanner LLP appointed on the same date.
Risks
- The company's related-party transactions, while disclosed, present potential conflicts of interest that require ongoing oversight.
- The proposed 2026 Equity Incentive Plan, if not approved, could necessitate higher cash compensation to attract and retain key employees.
- The company's insider trading policy prohibits hedging transactions, which could limit certain risk management strategies for executives and directors.
- The company has experienced changes in its independent auditors, which could raise questions about audit continuity or auditor independence, although no disagreements were reported.
Future Outlook
The company is seeking shareholder approval for the 2026 Equity Incentive Plan, which is intended to replace or supplement existing plans and provide flexibility in granting equity-based incentives. If not approved, the company may need to offer higher cash compensation to attract and retain employees.
Management Comments
- "Your vote is important. Whether you plan to attend the Annual Meeting in person or not, we hope you will vote your shares as soon as possible."
- "We value the opinions expressed by our shareholders in this advisory vote, and our Compensation Committee... will consider the outcome of the vote when designing our compensation programs and making future compensation decisions for our named executive officers."
- "The purpose of the 2026 Equity Incentive Plan is to promote CareClouds long term financial success, to attract, retain and reward persons who can contribute to the Companys success and to further align the participants interest with those of CareClouds shareholders."
Industry Context
StockSavvy.ai notes that the proposed 2026 Equity Incentive Plan is a common strategy in the healthcare technology sector to attract and retain talent in a competitive market. The focus on aligning executive and employee interests with shareholder value through equity awards is a standard practice.
Comparison to Industry Standards
- The proposed annual limit on non-employee director compensation under the 2026 Equity Incentive Plan is $300,000, which is within the typical range for companies of similar size and industry, though specific benchmarks would require detailed peer analysis.
- The company's use of restricted stock units (RSUs) and stock options as part of executive and director compensation aligns with industry standards for incentivizing performance and retention.
- The reduction of the quorum requirement from a majority to 33.4% of outstanding shares is a notable deviation from some traditional corporate governance standards, though it may be permissible under Delaware law and is intended to facilitate meeting transaction requirements.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | A. Hadi Chaudhry | 2026-03-10 | Ceased to be a director. | |
| Director | John N. Daly | 2025-11-01 | Passing of director. | |
| Director | Cameron P. Munter | 2026-03-24 | Appointed to the Audit Committee. | |
| Chief Executive Officer | A. Hadi Chaudhry | Stephen Snyder | 2026-01-01 | Transition in leadership roles. |
| Chief Strategy Officer | Stephen Snyder | A. Hadi Chaudhry | 2026-01-01 | Transition in leadership roles. |
| President | Crystal Williams | 2025-01-01 | Appointment to President role. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Bylaw Amendment | Amended bylaws to reduce the quorum requirement from a majority to 33.4% of the outstanding shares. | 2026-03-24 | Facilitates meeting quorum requirements for shareholder meetings, potentially allowing for business to be transacted with lower shareholder participation. |
| New Plan Adoption | Approval of the CareCloud, Inc. 2026 Equity Incentive Plan, subject to shareholder approval. | 2026-03-24 | Aims to enhance employee and director alignment with shareholders, attract and retain talent, and provide a flexible incentive structure. |
Related Party Transactions
- The Company had sales to a related party, the physician wife of the Executive Chairman, with revenues of approximately $125,000 in 2025 and $138,000 in 2024.
- The Company leases its corporate offices, foreign visitor housing, storage facility, backup operations center in Pakistan, and an apartment in Dubai from the Executive Chairman.
- Related party rent expense for leased facilities from the Executive Chairman was approximately $285,000 in 2025 and $281,000 in 2024.
- The Company spent approximately $1.6 million in 2025 and $979,000 in 2024 to upgrade facilities leased from the Executive Chairman, with 2025 expenditures focused on AI center expansion.
- The Company leases two facilities for temporary housing from a management employee for approximately $6,700 per month.
- During 2025, the Company employed the son of the current Chief Executive Officer, with salary expense of approximately $38,000.
- In July 2025, the Company entered into a consulting agreement with an entity owned by the son of the Executive Chairman for AI technology services, costing approximately $83,000 in 2025.
- A consulting agreement with an entity owned by a Board member for investor relations services was in place, with expenses of approximately $13,000 in 2025 and $75,000 in 2024, terminating in February 2026.
- A former non-independent director received shares of Series B Preferred Stock for consulting services related to acquisitions, with amendments extending the agreement and providing additional shares.
- The Company formed talkMD Clinicians, PA, a VIE, by the wife of the Executive Chairman to provide telehealth services; as of December 31, 2025, it had not commenced operations, with approximately $6,500 paid on its behalf for income taxes.
Stakeholder Impact
- Shareholders: Voting on director elections, executive compensation, and equity incentive plans directly impacts corporate governance and future incentive structures. Related-party transactions may raise concerns about management's focus and resource allocation.
- Employees: The proposed 2026 Equity Incentive Plan aims to provide incentives and align interests. Employment of executive officers' family members could raise concerns about meritocracy and fairness.
- Management: Executive compensation is subject to advisory shareholder vote. Related-party transactions involve key management personnel and their family members.
- Creditors: No direct impact mentioned, but ongoing operational and governance matters could indirectly affect financial stability.
Next Steps
- Shareholders are encouraged to vote their shares by June 4, 2026.
- The company will hold its Annual Meeting of Shareholders on June 4, 2026.
- Final voting results will be reported on a Form 8-K filed with the SEC following the meeting.
- Shareholder proposals for the 2027 Annual Meeting must be received by December 16, 2026 (for inclusion in proxy materials) or between January 30, 2027, and March 1, 2027 (for advance notice).
Key Dates
| Date | Description |
|---|---|
| 2023-01-01 | Start of fiscal year for which Pay Versus Performance data is presented. |
| 2024-01-01 | Start of fiscal year for which Pay Versus Performance data is presented. |
| 2024-03-12 | Filing date of Annual Report on Form 10-K for the fiscal year ended December 31, 2025. |
| 2024-03-24 | Date the Audit Committee approved the appointment of Rosenberg Rich Baker Berman, P.A. as new independent registered public accounting firm. |
| 2024-05-01 | Effective date of termination of consulting agreement with entity owned by former non-independent director. |
| 2025-01-01 | Start of fiscal year for which Pay Versus Performance data is presented. |
| 2025-08-14 | Date the Company accepted the resignation of Rosenberg Rich Baker Berman, P.A. as independent registered public accounting firm and appointed Tanner LLP. |
| 2025-11-01 | Date John N. Daly's service on the Compensation Committee ended due to passing. |
| 2026-01-01 | Effective date for Stephen Snyder becoming Chief Executive Officer. |
| 2026-01-15 | Termination date of the Equity Plan. |
| 2026-01-16 | Date for shareholder approval of the 2026 Equity Incentive Plan. |
| 2026-01-30 | Earliest date for shareholder proposals for the 2027 Annual Meeting of Shareholders. |
| 2026-03-10 | Date A. Hadi Chaudhry ceased to be a director. |
| 2026-03-24 | Date CareCloud's Board approved the 2026 Equity Incentive Plan. |
| 2026-04-07 | Record date for shareholders entitled to vote at the Annual Meeting. |
| 2026-04-15 | Date proxy materials will be first sent or given to shareholders. |
| 2026-05-29 | Deadline for all votes to be received by midnight. |
| 2026-06-04 | Date of the Annual Meeting of Shareholders. |
| 2026-12-16 | Deadline for shareholder proposals intended for inclusion in the proxy statement for the 2027 Annual Meeting of Shareholders. |
| 2027-01-30 | Latest date for shareholder proposals for the 2027 Annual Meeting of Shareholders. |
| 2027-04-05 | Deadline for shareholders intending to nominate directors for the 2027 Annual Meeting to provide notice. |
Recommendation
holdThe filing is a routine proxy statement for an annual meeting and does not contain new financial performance data or strategic shifts that would warrant a buy or sell recommendation. The proposals are standard for such meetings. The extensive related-party disclosures warrant a cautious 'hold' stance pending further clarity on their impact and oversight.
Keywords
CareCloud, Proxy Statement, Annual Meeting, Shareholder Vote, Director Election, Executive Compensation, Equity Incentive Plan, Tanner LLP, Corporate Governance, Related Party Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.